First-cycle novel drug approvals

STO-REC-STAT7HV4S9T1 Official
37

United States · 2024

First-cycle novel drug approvals in United States stood at 37 in 2024 (FDA).

Original source
Publisher
FDA
Authority tier
T1 Official
Locator
CDER’s Effectiveness Bringing New Therapies to Market
Retrieved
17 Sep 2026
Status
Verified

What the source says

First Cycle Approvals: 37 of the 50 novel drugs approved in 2024 (74%) were approved on the “first cycle” of review.

Verbatim extraction verified: The figure 37 is directly attested in the quoted passage (CDER’s Effectiveness Bringing New Therapies to Market).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_7HV4S9S7GYPN08FQAGH9VPCWB5
MLA
U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024, https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_7HV4S9S7GYPN08FQAGH9VPCWB5.
Chicago
U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024. https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_7HV4S9S7GYPN08FQAGH9VPCWB5.
BibTeX
@misc{fda2024firstvpcwb5, author = {{U.S. Food and Drug Administration}}, title = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_7HV4S9S7GYPN08FQAGH9VPCWB5}, note = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STAT7HV4S9 T1 Official

Primary Source

Publisher
U.S. Food and Drug Administration · homepage ↗
Authority tier
Tier 1 · Multilateral Official
Report
CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
Type
Press release
Published
Locator
CDER’s Effectiveness Bringing New Therapies to Market
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_7HV4S9S7GYPN08FQAGH9VPCWB5